Difference between revisions of "Foregut primary carcinomas"

From Libre Pathology
Jump to navigation Jump to search
Line 20: Line 20:


A (query) foregut primary panel for liver lesions:
A (query) foregut primary panel for liver lesions:
*AE1/AE3, CK7, CK20, CK19, CDX2, HepPar-1, CA-125, GATA3, PAX8, TTF-1.
*AE1/AE3, CK7, CK20, CK19, CDX2, HepPar-1, CA-125, GATA3, PAX8, WT-1, TTF-1.


==See also==
==See also==

Revision as of 18:06, 1 February 2021

Foregut primary carcinomas can be difficult to definitively categorize on the basis of pathology alone, as their immunostaining patterns significantly overlap.[1]

Foregut primary directs to this article.

Foregut

The foregut includes the following:

IHC

Foregut carcinomas are typically:

  • CK7 +ve.
  • CK20 -ve.
  • CDX2 -ve.

A (query) foregut primary panel for liver lesions:

  • AE1/AE3, CK7, CK20, CK19, CDX2, HepPar-1, CA-125, GATA3, PAX8, WT-1, TTF-1.

See also

References

  1. Lee, MJ.; Lee, HS.; Kim, WH.; Choi, Y.; Yang, M. (May 2003). "Expression of mucins and cytokeratins in primary carcinomas of the digestive system.". Mod Pathol 16 (5): 403-10. doi:10.1097/01.MP.0000067683.84284.66. PMID 12748245.
  2. Jennings RE, Berry AA, Kirkwood-Wilson R, Roberts NA, Hearn T, Salisbury RJ, Blaylock J, Piper Hanley K, Hanley NA (October 2013). "Development of the human pancreas from foregut to endocrine commitment". Diabetes 62 (10): 3514–22. doi:10.2337/db12-1479. PMC 3781486. PMID 23630303. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781486/.